Martin Louis Wilson - 03 Nov 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Counsel
Signature
/s/ Martin Louis Wilson
Issuer symbol
RCKT
Transactions as of
03 Nov 2025
Net transactions value
$0
Form type
4
Filing time
10 Nov 2025, 16:25:53 UTC
Previous filing
09 Sep 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wilson Martin General Counsel C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Louis Wilson 10 Nov 2025 0001704342

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Award $0 +100,000 +35% $0.000000 385,462 03 Nov 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026.